Additionally, the diet’s capacity to improve insulin sensitivity, reduce weight, and attenuate antipsychotic-induced hyperglycemia offers a rare dual benefit: targeting both psychiatric symptoms and physical health comorbidities that contribute to early mortality (Saha et al., 2007; Shamshoum et al., 2022; Biesiekierska et al., 2025). The gene discussed is INS; the disease is Hyperglycemia.